Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man (Q43947295)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 1, 1991

Language	Label	Description	Also known as
English	Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man	scientific article published on September 1, 1991

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man (English)

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

cholecystokinin

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

internal medicine

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Kerstin Uvnäs-Moberg

3

object named as

Uvnäs-Moberg K

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

5

object named as

Efendic S

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1

object named as

Ahrén B

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

M. Pettersson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683622

28 October 2022

M. Gutniak

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683622

28 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1683622

28 October 2022

publication date

1 September 1991

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:016882279190059M?httpAccept=text/xml

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

https://api.elsevier.com/content/article/PII:016882279190059M?httpAccept=text/plain

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Diabetes Research and Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

153-161

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas

3

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

GIP-like immunoreactivity in glucagon cells. Interactions between GIP and glucagon on insulin release

5

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats

6

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Effects of six cholecystokinin (CCK) fragments on insulin secretion in the mouse.

7

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Cholecystokinin (CCK)-4 and CCK-8 stimulate islet hormone secretion in vivo in the pig

8

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Effects of amino acids and gastric inhibitory polypeptide on insulin release in dogs

9

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice

10

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Cholecystokinin-33 potentiates and vasoactive intestinal polypeptide inhibits gastric inhibitory polypeptide--induced insulin secretion in the perfused rat pancreas

11

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans.

12

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Characterization of two novel forms of cholecystokinin isolated from bovine upper intestine

13

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Serum Levels of Human Pancreatic Polypeptide in Renal Disease

15

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Production and characterization of an antiserum against pancreatic glucagon

16

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Diminished Immunoreactive Gastric Inhibitory Polypeptide Response to a Meal in Newly Diagnosed Type I (Insulin-Dependent) Diabetics*

18

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

A stimulating effect of glucose on somatostatin release is impaired in noninsulin-dependent diabetes mellitus.

19

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Lack of insulinotropic effect of endogenous and exogenous cholecystokinin in man

21

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8

22

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Alpha 1- and alpha 2-adrenoceptor activation increases plasma glucagon levels in the mouse

24

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Effect of composition of mixed meals--low- versus high-carbohydrate content--on insulin, glucagon, and somatostatin release in healthy humans and in patients with NIDDM.

25

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas

27

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog

28

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro

29

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Cholecystokinin (CCK8) regulates glucagon, insulin, and somatostatin secretion from isolated rat pancreatic islets: interaction with glucose

30

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide

31

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus

32

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

The Insulinotropic Action of Gastric Inhibitory Polypeptide

33

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Influences of Gastro-Intestinal Polypeptides and Glucose on Glucagon Secretion Induced by Cholinergic Stimulation

34

1 reference

10.1016/0168-8227(91)90059-M

https://api.crossref.org/works/10.1016/0168-8227(91)90059-M

28 October 2022

Identifiers

10.1016/0168-8227(91)90059-M

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43947295&oldid=1759811286"